publication venue for
- Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients.. 43:463-471. 2008
- BACTERIA-SPECIFIC DRUG DELIVERY: HETERO-MULTIVALENT TARGETED LIPOSOMES FOR TREATMENT OF PSEUDOMONAS AERUGINOSA 2019
- SOCIALIZATION AMONG INPATIENTS WITH CYSTIC FIBROSIS VIA TECHNOLOGY AND AN INFECTION CONTROL-APPROVED NOVEL PLAYROOM 2015
- ESTROGEN CAUSES DYSREGULATED INFLAMMATION AND HINDERS THE INNATE IMMUNE RESPONSE TO PSEUDOMONAS AERUGINOSA INFECTION IN MICE 2014
- NOVEL METHOD TO MEASURE FAT AND PROTEIN DIGESTION RATE AND THE ACUTE RESPONSE TO PANCREATIC ENZYME INTAKE IN PEDIATRIC AND ADULT PATIENTS WITH CYSTIC FIBROSIS 2012
- DIETARY ESSENTIAL AMINO ACIDS ARE HIGHLY ANABOLIC IN PEDIATRIC PATIENTS WITH CYSTIC FIBROSIS CHARACTERIZED BY NUTRITIONAL FAILURE 2011
- NUTRITIONAL FAILURE IS ASSOCIATED WITH ENHANCED WHOLE BODY PROTEIN TURNOVER AND CATABOLISM IN PEDIATRIC PATIENTS WITH CYSTIC FIBROSIS 2011
- BODY MASS INDEX THRESHOLD TO PREDICT LOSS OF MUSCLE MASS & COMPROMISED LUNG FUNCTION IN PEDIATRIC PATIENTS WITH CYSTIC FIBROSIS 2010
- NEBULIZED SHELL CROSSLINKED NANOPARTICLES CARRYING BROAD-SPECTRUM SILVER-BASED ANTIMICROBIALS FOR DEPOT TREATMENT OF CYSTIC FIBROSIS PULMONARY INFECTIONS 2009
- Assessment of genetic modifiers for phenotypic severity of beta ENaC transgenic mice 2007